GLP-1 drugs show promise for more than weight loss. They also cut substance abuse and are changing how we think about the ...

GLP-1 (glucagon-like peptide-1) drugs, represented by ‘Wegovy’ and ‘Mounjaro’, are evolving beyond simple obesity treatments ...

Addiction is a condition that has long baffled physicians and philosophers, to say nothing of those struggling with it and those around them. People have long debated whether addiction is a habit or a ...

For years, addiction was seen as a matter of personal failure—a bad habit or a lack of discipline. People believed those who struggled with substance abuse could stop if they simply wanted to. But ...

Ramirez is an associate professor of psychological and brain sciences at Boston University. When philosophers imagined the ship of Theseus, they asked: Can a vessel that has all its planks replaced ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American Over the past year and a half, Scientific ...